Clinical Trial Update: Study of Cannabidiol in Sanfilippo Syndrome [Phase 2, Phase 3]

View source ↗

Summary

A cannabidiol study for Sanfilippo syndrome (Mucopolysaccharidosis type III) is recruiting participants for Phase 2 and Phase 3 at the Lundquist Institute affil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Type Iii
• Sanfilippo Syndrome

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Conditions: Sanfilippo Syndrome, Mucopolysaccharidosis III | Phase 2, Phase 3 | Status: RECRUITING